11/14
01:34 pm
atxs
Astria Therapeutics, Inc. (NASDAQ: ATXS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
Medium
Report
Astria Therapeutics, Inc. (NASDAQ: ATXS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
11/14
08:23 am
atxs
Astria Therapeutics, Inc. (NASDAQ: ATXS) had its price target raised by analysts at Oppenheimer Holdings Inc. from $26.00 to $28.00. They now have an "outperform" rating on the stock.
Medium
Report
Astria Therapeutics, Inc. (NASDAQ: ATXS) had its price target raised by analysts at Oppenheimer Holdings Inc. from $26.00 to $28.00. They now have an "outperform" rating on the stock.
11/13
04:22 pm
atxs
Astria Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update [Yahoo! Finance]
Medium
Report
Astria Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update [Yahoo! Finance]
11/13
04:10 pm
atxs
Astria Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
Medium
Report
Astria Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
11/13
08:00 am
atxs
Astria Therapeutics to Present at Upcoming Jefferies London Healthcare Conference
Medium
Report
Astria Therapeutics to Present at Upcoming Jefferies London Healthcare Conference
11/4
04:10 pm
atxs
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/2
09:03 pm
atxs
Ypsomed Holding (SWX:YPSN) Partners with Astria for STAR-0215 Autoinjector Amid Valuation Concerns [Yahoo! Finance]
Low
Report
Ypsomed Holding (SWX:YPSN) Partners with Astria for STAR-0215 Autoinjector Amid Valuation Concerns [Yahoo! Finance]
10/30
08:00 am
atxs
Astria Therapeutics to Present at Upcoming Canadian Society of Allergy and Clinical Immunology Annual Scientific Meeting
Low
Report
Astria Therapeutics to Present at Upcoming Canadian Society of Allergy and Clinical Immunology Annual Scientific Meeting
10/21
08:00 am
atxs
Astria Therapeutics to Present at Upcoming American College of Allergy, Asthma, and Immunology Annual Scientific Meeting
Low
Report
Astria Therapeutics to Present at Upcoming American College of Allergy, Asthma, and Immunology Annual Scientific Meeting
10/18
09:07 am
atxs
Companies Like Astria Therapeutics (NASDAQ:ATXS) Are In A Position To Invest In Growth [Yahoo! Finance]
Medium
Report
Companies Like Astria Therapeutics (NASDAQ:ATXS) Are In A Position To Invest In Growth [Yahoo! Finance]
10/16
08:00 am
atxs
European Commission Grants Orphan Medicinal Product Designation for Navenibart, Astria Therapeutics’ Investigational Therapy for the Treatment of Hereditary Angioedema
Low
Report
European Commission Grants Orphan Medicinal Product Designation for Navenibart, Astria Therapeutics’ Investigational Therapy for the Treatment of Hereditary Angioedema
10/2
04:10 pm
atxs
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
9/30
08:00 am
atxs
Astria Therapeutics Receives FDA Orphan Drug Designation for Navenibart (STAR-0215) for the Treatment of Hereditary Angioedema
Low
Report
Astria Therapeutics Receives FDA Orphan Drug Designation for Navenibart (STAR-0215) for the Treatment of Hereditary Angioedema
9/27
08:07 am
atxs
Astria Therapeutics, Inc. (NASDAQ: ATXS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
Low
Report
Astria Therapeutics, Inc. (NASDAQ: ATXS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
9/27
08:00 am
atxs
Astria Therapeutics to Present at Upcoming Global Angioedema Forum
Low
Report
Astria Therapeutics to Present at Upcoming Global Angioedema Forum
9/19
08:00 am
atxs
Astria Therapeutics to Present at Upcoming European Academy of Dermatology and Venerology Congress
Medium
Report
Astria Therapeutics to Present at Upcoming European Academy of Dermatology and Venerology Congress
9/4
04:10 pm
atxs
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
9/2
12:19 am
atxs
3 Swiss Stocks On The SIX Swiss Exchange With Estimated Discounts Up To 45% [Yahoo! Finance]
Medium
Report
3 Swiss Stocks On The SIX Swiss Exchange With Estimated Discounts Up To 45% [Yahoo! Finance]
8/30
08:00 am
atxs
Astria Therapeutics to Present at Upcoming Bradykinin Symposium
Medium
Report
Astria Therapeutics to Present at Upcoming Bradykinin Symposium
8/29
08:00 am
atxs
Astria Therapeutics to Participate in Upcoming Morgan Stanley 22nd Annual Global Healthcare Conference
Medium
Report
Astria Therapeutics to Participate in Upcoming Morgan Stanley 22nd Annual Global Healthcare Conference